-
-
-
-
-
-
-
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
-
-
-
-
-
-
-
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025
-
-
-
-
-
-
-
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
-
-
-
-
-
-
-
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2024
-
-
-
-
-
-
-
European Court of Justice rules in favor of Illumina in jurisdictional appeal
-
-
-
-
-
-
-
Gene-sequencing group Illumina sees $1.47 bn Q2 impairment charge linked to Grail
-
-
-
-
-
-
-
Illumina shares fall as Ichan reportedly abandons second proxy contest
-
1,158,431 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

